• The Eurasian Ice Sheet: Status and Challenges 

    Winsborrow, Monica Caroline Mackay; Hughes, Anna; Greenwood, Sarah L. (Conference object; Konferansebidrag, 2024-03-15)
  • Modelling the Eurasian Ice Sheet 

    Patton, Henry Jared (Conference object; Konferansebidrag, 2024-03-15)
  • Adapting a linguistic constructicon resource to L2 learners and instructors: a challenging endeavor 

    Endresen, Anna; Zhukova, Valentina; Janda, Laura Alexis (Conference object; Konferansebidrag, 2024-03)
    We present the challenges faced and decisions made in creating the Russian Constructicon (https://constructicon.github.io/russian/) as a multifunctional resource. We focus on two crucial categories of target users, linguists and L2 learners & instructors, and show that they have somewhat conflicting needs and expectations. While linguists want a maximally comprehensive inventory and its description, ...
  • Construxercise! A new digital resource with construction-based exercises for L2 Russian 

    Endresen, Anna; Janda, Laura Alexis; Zhukova, Valentina (Conference object; Konferansebidrag, 2024-03)
    In this talk, we will discuss how we can bridge the gap between a constructicon resource and second language (L2) learners, drawing our insights from the actual practice of construction-based teaching. We suggest that having a constructicon resource, even with a user-friendly design, might not be enough to successfully engage L2 students with its content. We 1) summarize the accommodations for L2 ...
  • VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study 

    Nørgaard, Jakob Nordberg; Moore, Kari Lenita Falck; Slørdahl, Tobias Schmidt; Vik, Anders; Tvedt, Tor Henrik Anderson; Schjesvold, Fredrik (Journal article; Tidsskriftartikkel; Peer reviewed, 2024-04-09)
    Induction therapy followed by autologous stem cell transplantation (ASCT) is standard of care for young and fit patients with newly diagnosed multiple myeloma (MM) [1]. Induction therapy has evolved from doublet to triplet to quadruplet regimens over the last decades. The most common triplet therapy is either Bortezomib-Cyclophosphamide-Dexamethasone (VCD), Bortezomib-Lenalidomide-Dexamethasone ...

View more